{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP02887",
    "Peptide Name": "p138c (natural AMPs; bacteriocins; Gram-positive bacteria, prokaryotes)",
    "Source": "Bacillus subtilisCSB138",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GLEETVYIYGANMAS",
    "Sequence Length": 15,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": -2,
    "Boman Index": 0.31,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "40%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Warning: The second amino acid at the C-terminus of the peptide is X (unknown), although represented here with A.Activity: Active against primarily Gram-positive bacteria E. faecalis ATCC 29212, S. aureus (MRSA) (MIC 0.62 ug/ml),  S. aureus KCTC 1928, Vancomycin-resistant S. aureus, M. luteus ATCC 9341, M. smegmatis ATCC 9341 (MIC 20-80 ug/ml), and Vancomycin-resistant Enterococci (MIC 10 ug/ml).  MBC at much higher concentrations 160-640 or greater.",
    "Author": "Regmi S, Choi YS, Choi YH, Kim YK, Cho SS, Yoo JC, Suh JW.2017",
    "Reference": "Int Microbiol. 2017 Mar;20(1):43-53. doi: 10.2436/20.1501.01.284.PubMed",
    "Title": "Antimicrobial peptide from Bacillus subtilis CSB138: characterization, killing kinetics, and synergistic potency."
  },
  "3D Structure": []
}